Cargando…

Characterisation of the genomic landscape of CRLF2‐rearranged acute lymphoblastic leukemia

Deregulated expression of the type I cytokine receptor, CRLF2, is observed in 5–15% of precursor B‐cell acute lymphoblastic leukaemia (B‐ALL). We aimed to determine the clinical and genetic landscape of those with IGH‐CRLF2 or P2RY8‐CRLF2 (CRLF2‐r) using multiple genomic approaches. Clinical and dem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russell, Lisa J., Jones, Lisa, Enshaei, Amir, Tonin, Stefano, Ryan, Sarra L., Eswaran, Jeyanthy, Nakjang, Sirintra, Papaemmanuil, Elli, Tubio, Jose M. C., Fielding, Adele K., Vora, Ajay, Campbell, Peter J., Moorman, Anthony V., Harrison, Christine J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396319/ https://www.ncbi.nlm.nih.gov/pubmed/28033648 http://dx.doi.org/10.1002/gcc.22439

Ejemplares similares

High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement
por: Ge, Zheng, et al.
Publicado: (2016)

Increased prevalence of CRLF2 rearrangements in obesity-associated acute lymphoblastic leukemia
por: Mittelman, Steven D., et al.
Publicado: (2021)

BCL6 inhibition ameliorates resistance to ruxolitinib in CRLF2-rearranged acute lymphoblastic leukemia
por: Tsuzuki, Shinobu, et al.
Publicado: (2022)

Epigenetic landscape correlates with genetic subtype but does not predict outcome in childhood acute lymphoblastic leukemia
por: Gabriel, Alem S, et al.
Publicado: (2015)

Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia
por: Sinclair, Paul B., et al.
Publicado: (2023)

Single nucleotide polymorphism array‐based signature of low hypodiploidy in acute lymphoblastic leukemia
por: Creasey, Thomas, et al.
Publicado: (2021)

Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials
por: Enshaei, Amir, et al.
Publicado: (2021)

CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition
por: Meyer, Lauren K., et al.
Publicado: (2019)

Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia
por: Li, Yilong, et al.
Publicado: (2014)

Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemia
por: Shi, Yuzhe, et al.
Publicado: (2020)

Multiparametric flow cytometry directing the evaluation of CRLF2 rearrangements and JAK2 status in pediatric B cell precursor acute lymphoblastic leukemia
por: Noronha, Elda Pereira, et al.
Publicado: (2023)

P344: ONCOGENESIS OF CRLF2 OVEREXPRESSION AND EFFECT OF A NOVEL JAK2 INHIBITOR IN CRLF2 OVEREXPRESSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
por: Gu, Yan, et al.
Publicado: (2023)

Single cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia
por: Potter, N, et al.
Publicado: (2018)

Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study
por: Moorman, Anthony V., et al.
Publicado: (2021)

TSLP as a Potential Therapy in the Treatment of CRLF2 B Cell Acute Lymphoblastic Leukemia
por: Alkashgari, Hossam R., et al.
Publicado: (2022)

Concordance of copy number abnormality detection using SNP arrays and Multiplex Ligation-dependent Probe Amplification (MLPA) in acute lymphoblastic leukaemia
por: Bashton, Matthew, et al.
Publicado: (2020)

Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia
por: O’Connor, David, et al.
Publicado: (2018)

Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials
por: Creasey, Thomas, et al.
Publicado: (2021)

Clinical characterization and prognosis of T cell acute lymphoblastic leukemia with high CRLF2 gene expression in children
por: Wang, Mingmin, et al.
Publicado: (2019)

Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial
por: Schwab, Claire, et al.
Publicado: (2022)

Genomic and transcriptional landscape of P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia
por: Vesely, C, et al.
Publicado: (2017)

The genomic landscape of teenage and young adult T‐cell acute lymphoblastic leukemia
por: Mansur, Marcela B., et al.
Publicado: (2021)

Genetic Profiles and Risk Stratification in Adult De Novo Acute Myeloid Leukaemia in Relation to Age, Gender, and Ethnicity: A Study from Malaysia
por: Ambayya, Angeli, et al.
Publicado: (2021)

SRC/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia
por: Sarno, Jolanda, et al.
Publicado: (2018)

CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia
por: Palmi, Chiara, et al.
Publicado: (2016)

Insights into protein kinase regulation and inhibition by large scale structural comparison
por: Eswaran, Jeyanthy, et al.
Publicado: (2010)

Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome–like acute B-cell lymphoblastic leukemia
por: Zhang, Qi, et al.
Publicado: (2018)

CRLF1 and CLCF1 in Development, Health and Disease
por: Crisponi, Laura, et al.
Publicado: (2022)

Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement
por: Bomken, Simon, et al.
Publicado: (2022)

Potential efficacy and prognosis of silencing the CRLF2-mediated AKT/mTOR pathway in pediatric acute B-cell lymphoblastic leukemia
por: Jiang, Min, et al.
Publicado: (2019)

IKZF1 deletions associate with CRLF2 overexpression leading to a poor prognosis in B-cell precursor acute lymphoblastic leukaemia
por: Maciel, Ana Luiza Tardem, et al.
Publicado: (2021)

The enigmatic role(s) of P2RY8-CRLF2
por: Panzer-Grümayer, Renate, et al.
Publicado: (2017)

CRLF1 Is a Key Regulator in the Ligamentum Flavum Hypertrophy
por: Zheng, Zhenyu, et al.
Publicado: (2020)

CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways
por: Moreno Lorenzana, Dafné, et al.
Publicado: (2021)

Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes
por: Lin, Danna, et al.
Publicado: (2023)

Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia
por: Leongamornlert, Daniel, et al.
Publicado: (2023)

The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia
por: Østergaard, Anna, et al.
Publicado: (2023)

Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platform
por: Enshaei, Amir, et al.
Publicado: (2023)

Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia
por: Ryan, Sarra L., et al.
Publicado: (2023)

Gain of chromosome 21 increases the propensity for P2RY8: :CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression
por: Page, Elyse C., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9vmg9cfukj54ghor308i26a3lj